Advertisement

Topics

Integra LifeSciences Company Profile

13:25 EDT 22nd June 2018 | BioPortfolio

Integra LifeSciences Corporation develops, manufactures and markets medical devices, implants and biomaterials primarilyused in the treatment of burns and skin defects, spinal and cranial disorders, orthopedics and other surgical applications. Integra seeks to be the world's leading company specializing in implantable medical and biopharmaceutical therapies to target and control cell behavior, and to build shareholder value by acquiring, discovering, and developing cost-effective, off-the-shelf products that satisfy unmet medical needs.

Location

311 Enterprise Drive
Plainsboro
NJ
08536
United States of America

Contact

Phone: 1-800-654-2873 or 1-609-275-0500 Outside U.S
Fax: 609 799 3297
Email: custsvcnj@integra-ls.com


News Articles [139 Associated News Articles listed on BioPortfolio]

Offering pulls in $350M for Integra LifeSciences

An offering of about 5.3 million shares of common stock was closed by Integra LifeSciences, bringing in $350 million after un -More- 

Integra LifeSciences nets $303.8mm through public offering

Integra LifeSciences Holdings Corp. (instruments and devices for reconstructive and general surgery, neurosurgery, and orthopedic extremity surgery) netted $303.8mm through a public offering of 5.25mm...

Investor Network: Integra LifeSciences Holdings Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 27, 2018 / Integra LifeSciences Holdings Corporation (NASDAQ: IART) will be discussing their earnings results in their Q4 Earnings Call to be held on February 2...

Integra announces terms of $307M offering, $2.2B credit facility amendment

A public offering of about 5.3 million shares of common stock was priced by Integra LifeSciences at $58.50 each in hopes of r -More- 

Integra LifeSciences Holdings Corporation Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 16022018] Prices from USD $350

Integra LifeSciences Holdings Corporation Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Integra LifeSciences Holdings Corporation Mergers Acquisitions MA...

Integra LifeSciences Holdings (IART) Q1 2018 Results - Earnings Call Transcript

Integra LifeSciences Holdings Corporation 2018 Q1 - Results - Earnings Call Slides

Integra LifeSciences Holdings (IART) Q4 2017 Results - Earnings Call Transcript

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Tandem plus [Physicians Total Care, Inc.]

see all prescribing information for Tandem

Integra f [US Pharmaceutical Corporation]

see all prescribing information for Integra F

Integra plus [US Pharmaceutical Corporation]

see all prescribing information for Integra Plus

Fluconazole [Claris Lifesciences Inc.]

Fluconazole Injection For Intravenous Use OnlyRx only

Metronidazole [Claris Lifesciences Inc.]

Metronidazole Injection, USP

PubMed Articles [11 Associated PubMed Articles listed on BioPortfolio]

Integra-Dermal Regeneration Template and Split-Thickness Skin Grafting: A Therapy Approach to Correct Aplasia Cutis Congenita and Epidermolysis Bullosa in Carmi Syndrome.

The association of junctional epidermolysis bullosa with pyloric atresia (JEB-PA) and aplasia cutis congenita (ACC) was described by El Shafie et al. (J Pediatr Surg 14(4):446-449, 1979) and Carmi et...

Efficacy of a Nanofabricated Electrospun Wound Matrix in Treating Full-thickness Cutaneous Wounds in a Porcine Model.

This study aims to evaluate the comparative performance of a resorbable nanofiber wound matrix (Restrata Wound Matrix; Acera Surgical Inc, St Louis, MO) and a bilayered collagen xenograft (Integra Bil...

Long-term follow-up comparison of two different bi-layer dermal substitutes in tissue regeneration: Clinical outcomes and histological findings.

Double layer dermal substitute (DS) consist of a 3-dimensional collagen structures and a superficial silicon layer that are positioned within the defect provide to promote tissue regeneration in skin ...

Impact of integration of sexual and reproductive health services on consultation duration times: results from the Integra Initiative.

The lack of human resources is a key challenge in scaling up of HIV services in Africa's health care system. Integrating HIV services could potentially increase their effectiveness and optimize the us...

Goal-Directed Fluid Resuscitation Protocol Based on Arterial Waveform Analysis of Major Burn Patients in a Mass Burn Casualty.

Adequate fluid titration during the initial resuscitation period of major burn patients is crucial. This study aimed to evaluate the feasibility and efficacy of a goal-directed fluid resuscitation pro...

Clinical Trials [32 Associated Clinical Trials listed on BioPortfolio]

Single-Stage Integra Reconstruction in Burns

This is a prospective, descriptive, pilot case series involving patients with significant burns who are candidates for reconstruction with Integra®. Subjects would have a small area of th...

Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers

- After determining if subjects meet the criteria to be included in the study, the wound will be debrided (cleansed of any dead tissue or infection). - Subjects will then be rand...

The Use of Integra in Coverage of Radial Forearm Free Flap Donor Site Defect

The purpose of this research study is to compare the forearm free flap of patients with a traditional split thickness skin graft and those repaired with Integra (a skin substitute that hel...

Comparing the Clinical Outcomes of DermACELL® With Integra® Bilayer Wound Matrix

Both DermACELL® and Integra® Bilayer Wound Matrix are indicated for deep soft tissue coverage and serve as a biological matrix for cellular migration. The current thinking about the util...

Clinical Evaluation of the TITAN™ Total Shoulder System

A post market, non-randomized, multi-center, open-label,clinical study using survivorship to study the safety and efficacy of the Integra® TITAN™ Total Shoulder System 1.0 (TAS) when us...

Companies [40 Associated Companies listed on BioPortfolio]

Integra LifeSciences

Integra LifeSciences Corporation develops, manufactures and markets medical devices, implants and biomaterials primarilyused in the treatment of burns and skin defects, spinal and cranial disorders, o...

Integra Holdings

Founded by Yissum, Integra Holdings is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in the...

Integra NeuroSciences

Integra LifeSciences Holdings Corporation is a diversified medical technology company that develops, manufactures, and markets medical devices for use in a variety of applications. The primary applica...

INTEGRA Holding Ltd.

INTEGRA Holding Ltd. is a Swiss financial holding company with shareholdings in companies in a variety of markets at home and abroad. The current INTEGRA portfolio comprises market segments in real es...

Integra ServiceConnect®, LLC

Integra ServiceConnect® connects people to services they need to improve their health. With the recognition that 80% of health outcomes are driven by non-clinical social factor...

More Information about "Integra LifeSciences" on BioPortfolio

We have published hundreds of Integra LifeSciences news stories on BioPortfolio along with dozens of Integra LifeSciences Clinical Trials and PubMed Articles about Integra LifeSciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Integra LifeSciences Companies in our database. You can also find out about relevant Integra LifeSciences Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...


Corporate Database Quicklinks



Searches Linking to this Company Record